AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Osimertinib
6 registrations across 3 African markets— 6 active
Markets with Osimertinib
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Tagrisso 80mg Tablets Film Coated Tablets | 🇿🇲Zambia | Astra Zeneca UK Limited | active | Sept 2030 |
| Tagrisso 40mg Tablets Tablet, Filmcoated | 🇿🇲Zambia | Astra Zeneca UK Limited | active | Sept 2030 |
| Tagrisso 80 mg Film-Coated Tablets Tablet | 🇳🇬Nigeria | AstraZeneca Nigeria Limited | active | Oct 2026 |
| Tagrisso 40 mg Film Coated Tablets Tablet | 🇳🇬Nigeria | AstraZeneca Nigeria Limited | active | Oct 2026 |
| TAGRISSO 40mg Film Coated Tablet | 🇹🇿Tanzania | AstraZeneca UK Limited | active | — |
| TAGRISSO 80mg Film Coated Tablet | 🇹🇿Tanzania | AstraZeneca UK Limited | active | — |
Osimertinib in Africa — Regulatory Overview
Osimertinib is registered across 3 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Tanzania, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 6 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.